Cambridge Investment Research Advisors
BSTZ icon

Cambridge Investment Research Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BSTZ Stock Details BSTZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
16,613
+3,221
+24% +$88.9K ﹤0.01% 2957
2026
Q1 		$297K Buy
13,392
+357
+3% +$8.01K ﹤0.01% 3303
2025
Q4 		$295K Buy
13,035
+883
+7% +$19.7K ﹤0.01% 3222
2025
Q3 		$269K Buy
+12,152
New +$261K ﹤0.01% 3204
2025
Q2 		– Sell
-56,520
Closed -$1M – 3637
2025
Q1 		$1M Sell
56,520
-2,425
-4% -$49.5K ﹤0.01% 1866
2024
Q4 		$1.22M Buy
58,945
+4,023
+7% +$83K ﹤0.01% 1711
2024
Q3 		$1.05M Sell
54,922
-7,455
-12% -$142K ﹤0.01% 1826
2024
Q2 		$1.24M Buy
62,377
+6,954
+13% +$130K ﹤0.01% 1619
2024
Q1 		$1.07M Buy
55,423
+6,587
+13% +$118K ﹤0.01% 1678
2023
Q4 		$816K Buy
48,836
+4,338
+10% +$70.2K ﹤0.01% 1792
2023
Q3 		$734K Buy
44,498
+15,238
+52% +$269K ﹤0.01% 1776
2023
Q2 		$530K Buy
29,260
+1,205
+4% +$20.7K ﹤0.01% 2095
2023
Q1 		$524K Buy
28,055
+6,245
+29% +$110K ﹤0.01% 2048
2022
Q4 		$341K Buy
21,810
+4,656
+27% +$79.2K ﹤0.01% 2326
2022
Q3 		$303K Buy
17,154
+454
+3% +$9.35K ﹤0.01% 2351
2022
Q2 		$327K Buy
16,700
+476
+3% +$11.2K ﹤0.01% 2306
2022
Q1 		$477K Buy
16,224
+6,167
+61% +$184K ﹤0.01% 2137
2021
Q4 		$392K Buy
10,057
+689
+7% +$27.5K ﹤0.01% 2302
2021
Q3 		$361K Sell
9,368
-139
-1% -$5.64K ﹤0.01% 2304
2021
Q2 		$397K Buy
9,507
+1,136
+14% +$43.1K ﹤0.01% 2242
2021
Q1 		$299K Sell
8,371
-44
-0.5% -$1.6K ﹤0.01% 2289
2020
Q4 		$306K Sell
8,415
-1,538
-15% -$47.4K ﹤0.01% 2119
2020
Q3 		$255K Buy
+9,953
New +$249K ﹤0.01% 2057

Other funds holding BSTZ

Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Cambridge Investment Research Advisors's BSTZ Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its BlackRock Science and Technology Term Trust (BSTZ) stake by 24% in Q2 2026, buying an estimated $88.9K and bringing the position to 16,613 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

Cambridge Investment Research Advisors first reported a position in BSTZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.24M in Q2 2024. 151 funds tracked by Wall St. Rank hold BSTZ as of Q2 2026.

  • Cambridge Investment Research Advisors held 16,613 shares of BlackRock Science and Technology Term Trust worth $499K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,221 BlackRock Science and Technology Term Trust shares in Q2 2026, an estimated $88.9K.
  • BlackRock Science and Technology Term Trust made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2957 holding.
  • Cambridge Investment Research Advisors first reported a position in BlackRock Science and Technology Term Trust in Q3 2020 and has held it in 23 quarters since.
  • Cambridge Investment Research Advisors's BlackRock Science and Technology Term Trust position peaked at $1.24M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.